AC01 for Heart Failure
(GOAL-HF2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanced HFrEF.
Are You a Good Fit for This Trial?
This trial is for adults with chronic heart failure (diagnosed at least 6 months ago) whose heart's pumping ability is reduced (LVEF ≤35%). Participants must have stable treatment, specific heart rhythms and rates, and certain blood test results. Some types of irregular heartbeat are limited in the study.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- AC01
Trial Overview
The study compares two doses of a new drug called AC01 to a placebo over 12 weeks to see if AC01 is safe and effective for people with advanced chronic heart failure. Participants are randomly assigned to one of the groups.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Participants will receive AC01 orally twice daily (BID) for 12 weeks.
Participants will receive AC01 orally BID for 12 weeks.
Participants will receive matching placebo orally BID for 12 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
AnaCardio AB
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.